Insulet Honors Diabetes Awareness with Global Activities and Events


Enter Wall Street with Street Insider Premium. Claim your 1-week free trial here.


ACTON, Mass .– (BUSINESS WIRE) – Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the world leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced various activities to recognize Diabetes Awareness Month and World Diabetes Day during the month of November.

“We are passionate about improving the lives of people with diabetes and at Insulet we strive to make Pod Therapy universally accessible to anyone in need of daily insulin,” said Shacey Petrovic, President and Chief Executive Officer. The direction. “With more than 400 million people living with diabetes worldwide and 11 to 12 million in the countries we serve today, we are committed to making an impact on this global epidemic. ”

Insulet will virtually ring the closing bell for the Nasdaq stock market on Monday, November 15. Ms. Petrovic will be joined by members of the Insulet community who have made significant contributions to the company’s latest innovative product, the Omnipod 5® automated insulin delivery system, including employees as well as clinical trial participants and health care providers. Omnipod 5 will be the first automated tubeless insulin delivery system with compatible smartphone control in the United States.

Throughout November, Insulet will sponsor various community events, including Children with Diabetes’ Virtual Friends for life, Risely Health DT1 set, and beyond types 1 Community table focusing on the language of diabetes. The company has also partnered with Senita to offer a collection of fitness clothing with a portion of the proceeds funding scholarships for students living with diabetes.

Insulet will participate in several multimedia campaigns on its social media channels to increase awareness of type 1 and type 2 diabetes and to support and empower people with diabetes. Rebecca Redmond, Omnipod customer and relative of insulin co-discoverer Dr. Frederick Banting, will be featured on multiple channels and named Podder of the Month. Other Omnipod brand ambassadors will also share personal stories on their blogs and social media.

On World Diabetes Day, November 14, the Society will highlight the power and diversity of the diabetes community in a social media video. This content supports the International Diabetes Federation (IDF) theme for World Diabetes Day 2020, which is Access to Diabetes Care.

Insulet employees will also help raise awareness throughout the month of November with a variety of activities, including sharing their personal stories about living with illness and wearing blue on Fridays, which is the color symbolizing diabetes.

To learn more about diabetes or to access helpful resources for living with diabetes, visit the American Diabetes Association, JDRF, and the International Diabetes Federation.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making life easier for people with diabetes and other conditions through its platform of products Omnipod. The Omnipod Insulin Management System offers a unique alternative to traditional methods of insulin delivery. With its simple and portable design, the Disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also takes advantage of its unique Pod design by adapting its Omnipod technology platform for subcutaneous drug delivery without insulin in other therapeutic areas. For more information, visit: insulet.com and omnipod.com

Forward-looking statement:

This press release may contain forward-looking statements regarding Insulet’s expectations, expectations, intentions, beliefs or strategies regarding the future. These forward-looking statements are based on its current expectations and beliefs regarding future developments and their potential effects on Insulet. There can be no assurance that future developments affecting Insulet will be as anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond its control) or other assumptions that may cause actual results or performance to differ materially from those expressed or implied by these forward-looking statements, and other risks and uncertainties described in its annual report on Form 10-K, which was filed with the Securities and Exchange Commission on February 24, 2021 in the section entitled “Risk Factors”, and in its other filings from time to time with the Securities and Exchange Commission. If one or more of these risks or uncertainties materialize, or if any of its assumptions turn out to be incorrect, actual results could differ in material respects from those projected in these forward-looking statements. Insulet assumes no obligation to publicly update or revise any forward-looking statements.

© 2021 Insulet Corporation. Omnipod and Omnipod 5 are registered trademarks of Insulet Corporation in the United States of America and other jurisdictions. All other trademarks are the property of their respective owners. Use of third-party trademarks does not constitute an endorsement or imply a relationship or other affiliation. All rights reserved.

Investor Relations:

Deborah R. Gordon

Vice-President, Investor Relations

(978) 600-7717

[email protected]

Media:

Angela Geryak Wiczek

Senior Director, Corporate Communications

(978) 932-0611

[email protected]

Source: Insulet Corporation


Source link

Richard V. Johnson

Leave a Reply

Your email address will not be published. Required fields are marked *